| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.58 | 0.0009 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.001 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |